A novel multivalent mRNA vaccine demonstrated robust immunogenicity and protection against monkeypox virus in murine models, marking a pivotal advance amid resurging zoonotic threats. The study underlines mRNA platforms' adaptability for emerging viral pathogens and expands the toolkit for pandemic preparedness. This vaccine candidate may offer a strategic option to curb future monkeypox outbreaks.